City of Hope researchers demonstrate proof of concept for a novel targeted therapy for pancreatic cancer, exploiting ...

Converging computational and laboratory technologies are helping anti-cancer immune responses hit their target more effectively.

Results of a study show convergent genetic adaptation under hypoxia (lack of oxygen) between populations living at ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment ...

Caris Life Sciences has collected $168 million in new funding to support the growth of its precision medicine platforms, ...

From new KRAS and HER2 inhibitors to home-administered immunotherapy, recent trials mark a turning point in how metastatic lung cancer is managed.

Global demand for anatomic pathology is accelerating, driven by clinical complexity, molecular integration, AI adoption, ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients show molecular alterations in the ALK gene involved in cell multiplication.

Results of a VHIO led study show that up to 90% of chronically hypoxic patients have an EPAS1 alteration in their tumor, a ...

Edible Garden AG Incorporated ("Edible Garden" or the "Company") (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally ...